NATALIYA BILAN: Open Payments
NPI 1558870022 · ENUMCLAW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 31 payments from 11 companies in 2025. Trend: 2023 $174 · 2024 $619 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $314 |
| AstraZeneca Pharmaceuticals LP | 8 | $160 |
| GENZYME CORPORATION | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| 3B Medical, Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| ALK-Abello, Inc | 1 | $21 |
Products named: NUCALA, DUPIXENT, AIRSUPRA, FASENRA, TRELEGY ELLIPTA, NEFFY, INSPIRE, LUNA.
Industry payments across WA — which companies pay providers there.
